期刊文献+

脑膜瘤MMP-9表达及其临床病理学意义

Study on expression of MMP-9 in meningiomas and its relationship to clinicopathology
下载PDF
导出
摘要 目的 :研究脑膜瘤中MMP 9的表达和临床病理学意义。方法 :应用免疫组织化学SP法检测 5 2例脑膜瘤组织中MMP 9表达情况 ,并结合临床病理参数进行综合分析。结果 :MMP 9的表达和脑膜瘤病理分级、侵袭行为、瘤周水肿显著相关 (P <0 0 5 ) ,而和患者病情分级、肿瘤切除范围、肿瘤分型、肿瘤部位、肿瘤形状、大小无关 (P >0 0 5 )。结论 :MMP 9在肿瘤恶性转化和浸润、瘤周水肿等方面起着重要作用。检测脑膜瘤MMP 9的表达对了解脑膜瘤生物学行为和判断预后有重要价值。 Objective: To investigate the expression and clinicopathologic significance of MMP-9 in meningiomas.Methods: Expression of MMP-9 in 52 cases of meningiomas were detected by immunohistochemistry SP method. The clinical pathological parameters were analyzed at the same time.Results: The expression of MMP-9 positively correlated with pathological grade, aggressive behavior and peritumoral edema(P<0.05),but their relation to the patient's condition, the resection grade(Simpson), histological variation, tumor location, size, and border shape(P>0.05).Conclusion: In meningiomas, MMP-9 may play an important role during malignancy conversion, and invasion and peritumoral edema. Dection expression of MMP-9 may be of value in understanding the biological behavior and predicting the prognosis of meningiomas.
出处 《河南医学研究》 CAS 2003年第4期328-330,共3页 Henan Medical Research
关键词 脑膜瘤 MMP-9 病理学意义 免疫组织化学SP法 肿瘤转移 肿瘤浸润 肿瘤生物学 MMP-9 meningiomas clinicopathology immunohistochemistry
  • 相关文献

参考文献9

  • 1[1]Louis DN,Scheithauer BW,Budka H,et al.Meningiomas.In:Kleihues P,Cavenee WK(eds).WHO Classification of Tumours:Pathology and genetics tumours of the nervous system (ed2)[M].Lyon:IARC Press,2000.1-314.
  • 2[2]Kallio M,Sankila R,Hakulinen T,et al.Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningiomas[J].Neurosurgery,1992,31(1):2-12
  • 3[3]Goldman CK,Bharara S,Palmer CA,et al.Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression[J].Neurosurgery,1997,40(6):1269-1277.
  • 4[4]Ann GP,Robert D,Marie-Jeanette F,et al.Stromelysin-3 is expressed by aggressive meningiomas[J].Cancer,2002,94(3):765-772.
  • 5[5]Franchi A,Santucci M,Masini E,et al.Expression of matrix metalloproteinase 1,matrix metalloproteinase 2,and matrix metalloproteinase 9,in carcinoma of the head and neck[J].Cancer,2002,95(9):1902-1910.
  • 6[6]Massova I,Kotra LP,Fridman R,et al.Matrix metalloproteinases:structures, evolution,and diversificatin[J].Faseb J,1998,12(12):1075-1095.
  • 7[7]Mizoue T,Kawamoto H,Arita K,et al.Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis[J].Acta Neurochair (Wien),1999,141(5):481-486.
  • 8[8]Nordqvist AC,Smurawa H,Mathiesen T.Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema[J].J Neurosurg,2001,95(5):839-844.
  • 9[9]Paek SH,Kim CY,Kim YY,et al.Correlation of clinical and biological parameters with peritumoral edema in meningioma[J].J Neurooncol,2002,60(3):235-245.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部